TipRanks
GT Biopharma (DE:OXI)
FRANKFURT:OXI
Germany Market
OXI
GT Biopharma
RESEARCH TOOLSreports

GT Biopharma (OXI) Balance Sheet

0 Followers

GT Biopharma Balance Sheet

GT Biopharma's total assets for Q2 2026 were $5.79M, a decrease of -42.10% from the previous quarter. DE:OXI total liabilities were $2.22M for the fiscal quarter, a -8.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 8.11M$ 4.23M$ 14.11M$ 16.74M$ 32.17M
Total Liabilities
$ 2.32M$ 5.90M$ 6.63M$ 5.00M$ 10.26M
Total Equity Gross Minority
$ 5.79M$ -1.67M$ 7.48M$ 11.73M$ 21.91M
Other Metrics
Currency in USD

GT Biopharma Debt to Assets